SXL
GILD icon

Summit X LLC’s Gilead Sciences GILD Stock Holding History

Summit X LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,499
Closed -$2.38M – 92
2025
Q2 		$2.38M Sell
21,499
-55
-0.3% -$5.85K 0.44% 43
2025
Q1 		$2.41M Sell
21,554
-901
-4% -$93K 0.51% 39
2024
Q4 		$2.07M Sell
22,455
-288
-1% -$25.9K 0.46% 44
2024
Q3 		$1.56M Sell
22,743
-764
-3% -$58.3K 0.38% 56
2024
Q2 		$1.61M Buy
23,507
+1,682
+8% +$112K 0.36% 63
2024
Q1 		$1.6M Buy
21,825
+1,571
+8% +$121K 0.41% 51
2023
Q4 		$1.64M Sell
20,254
-427
-2% -$33.2K 0.47% 45
2023
Q3 		$1.55M Sell
20,681
-3,262
-14% -$251K 0.49% 41
2023
Q2 		$1.85M Buy
23,943
+1,317
+6% +$105K 0.45% 41
2023
Q1 		$1.88M Buy
22,626
+618
+3% +$51.2K 0.49% 39
2022
Q4 		$1.36M Sell
22,008
-869
-4% -$68.8K 0.39% 57
2022
Q3 		$1.41M Buy
22,877
+865
+4% +$54.5K 0.42% 57
2022
Q2 		$1.36M Buy
22,012
+389
+2% +$24.1K 0.39% 57
2022
Q1 		$1.29M Buy
21,623
+1,401
+7% +$89.6K 0.32% 69
2021
Q4 		$1.47M Buy
20,222
+900
+5% +$62K 0.34% 66
2021
Q3 		$1.35M Buy
19,322
+968
+5% +$68K 0.34% 65
2021
Q2 		$1.27M Buy
18,354
+326
+2% +$21.8K 0.32% 71
2021
Q1 		$1.16M Sell
18,028
-6,695
-27% -$432K 0.32% 76
2020
Q4 		$1.44M Buy
+24,723
New +$1.49M 0.42% 57
2020
Q2 		$2.21M Buy
28,649
+826
+3% +$63.3K 0.82% 33
2020
Q1 		$2.07M Sell
27,823
-11,735
-30% -$811K 0.97% 27
2019
Q4 		$2.57M Buy
39,558
+3,630
+10% +$236K 0.95% 25
2019
Q3 		$2.28M Buy
+35,928
New +$2.35M 0.91% 26
2017
Q4 		– Sell
-3,440
Closed -$277K – 181
2017
Q3 		$277K Sell
3,440
-139
-4% -$10.6K 0.18% 144
2017
Q2 		$253K Buy
+3,579
New +$238K 0.18% 157

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Summit X LLC's GILD Position: Q3 2025 in Review

Summit X LLC sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 21,499 shares — an estimated $2.38M sold.

Summit X LLC first reported a position in GILD in Q2 2017 and held it in 25 quarters. The position peaked at $2.57M in Q4 2019. 2,032 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Summit X LLC reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Summit X LLC sold 21,499 Gilead Sciences shares in Q3 2025, an estimated $2.38M.
  • Summit X LLC first reported a position in Gilead Sciences in Q2 2017 and held it in 25 quarters.
  • Summit X LLC's Gilead Sciences position peaked at $2.57M in Q4 2019.
  • 2,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Summit X LLC's 13F filing for Q3 2025.